Tower Bersama Infrastructure
TBIG has released its 1H24 results. Headline 1H24 profit of IDR731bn (+6% y-y) came in slightly behind our FY2
We adjust our earnings estimates post 4Q24 results; maintain Buy with higher TP of IDR3,600
ISAT released expected 4Q24 results, with headline profit of IDR1.0tn (-10% q-q). The declining profitability q-q was due to: 1) weaker purchasing power; 2) a still intense competitive landscape; 3) a declining subscriber base q-q to 94.7mn (see Fig. 5); and 4) possibly the increasing presence of illegal ISPs that compete with cellular companies’ data services. Still, we reaffirm Buy on ISAT. We raise FY25F/26F earnings by +33%/ +40% on the back of the lower cost of SIM cards (-24%/-26%) and concession and license fees (-16%/-21%), and introduce forecasts for FY27F. At the operating level, we project revenue and EBITDA to be ~2% and ~4-5% higher than our previous projections. Further out, ISAT aims to divest its fiber infrastructure, which we value at an EV of ~USD500-1,500mn. It is still early, but we think the company would prefer cash and stake payments. If successful, this could be a key near-term share price catalyst for ISAT.
4Q24 results summary: Subscriber base back to 94.8mn (same level as 1Q22)
4Q revenue was IDR14.1tn (+2% q-q, +2% y-y) bringing FY24 revenue to IDR55.9tn (+9% y-y). Mobile drove growth, with 4Q24 revenue at IDR11.8tn (+1% q-q, +2% y-y), implying FY24 revenue at IDR47.0tn (+8% y-y). ISAT’s subscriber base declined to 94.7mn users (-4% q-q / y-y), while ARPU rose to IDR38,000 (+4% q-q; +1% y-y), reflecting more rational behavior (i.e., reducing sales of starter packages [SPs]). Unfortunately, competition remains intense particularly from XL Axiata (EXCL IJ, Buy) which sold cheaper SPs. Excluding these, we think ISAT’s ARPU uplift could have been higher in 4Q24. 4Q24 EBITDA was IDR6.4tn (-3% q-q, -2% y-y), bringing FY24 EBITDA to IDR26.4tn (+10% y-y). Implied EBITDA margin reached 47.2% in FY24 (up a mere 50bp y-y). For mobile, given the soft top line, EBITDA for cellular units was IDR5.6tn (-1% q-q / -3% y-y). This brings cellular-only FY24 EBITDA of IDR26.4tn (+10% y-y). 4Q24 profit was IDR1.1tn (-10% q-q / -40% y-y), translating into FY24 profit of IDR4.9tn (+9% y-y).
Valuation and risks
We derive our DCF-based TP of IDR3,600 (up from IDR3,450) using the following key parameters: a risk-free rate of 6.2%, an equity risk premium of 7.4%, beta of 1.2x and a terminal growth rate of 2.5%. At our TP, the stock would trade at 7.0x FY25F EV/EBITDA (vs 4.0x at the current price). Key risks include adverse macroeconomic trends that could impact purchasing power, lower price increases or subscriber bases, higher opex due to slower post-merger network integration, and/or irrational competition leading to price cuts.
Year-end 31 Dec | FY24 | FY25F | FY26F | FY27F | |||
Currency (IDR) | Actual | Old | New | Old | New | Old | New |
Revenue (bn) | 55,887 | 57,533 | 58,569 | 58,488 | 59,505 | 0 | 60,603 |
Reported net profit (bn) | 4,911 | 4,045 | 5,371 | 4,491 | 6,297 | 0 | 6,870 |
Normalised net profit (bn) | 4,911 | 4,045 | 5,371 | 4,491 | 6,297 | 0 | 6,870 |
FD normalised EPS | 152.27 | 125.43 | 166.53 | 139.25 | 195.26 | 213.01 | |
FD norm. EPS growth (%) | -72.8 | 4.8 | 9.4 | 11.0 | 17.3 | 9.1 | |
FD normalised P/E (x) | 12.6 | – | 11.5 | – | 9.8 | – | 9.0 |
EV/EBITDA (x) | 4.6 | – | 4.0 | – | 3.8 | – | 3.6 |
Price/book (x) | 1.8 | – | 1.7 | – | 1.6 | – | 1.5 |
Dividend yield (%) | 3.8 | – | 4.8 | – | 5.6 | – | 6.1 |
ROE (%) | 15.3 | 11.6 | 15.5 | 11.9 | 16.9 | 17.0 | |
Net debt/equity (%) | 150.5 | 104.3 | 115.4 | 81.8 | 93.3 | 75.0 | |
Income statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY23 | FY24 | FY25F | FY26F | FY27F | ||||||||||||||
Revenue | 51,229 | 55,887 | 58,569 | 59,505 | 60,603 | ||||||||||||||
Cost of goods sold | -37,383 | -40,292 | -41,207 | -41,166 | -41,381 | ||||||||||||||
Gross profit | 13,846 | 15,595 | 17,362 | 18,340 | 19,222 | ||||||||||||||
SG&A | -835 | -889 | -881 | -895 | -912 | ||||||||||||||
Employee share expense | -3,695 | -3,890 | -4,832 | -4,909 | -5,000 | ||||||||||||||
Operating profit | 9,317 | 10,817 | 11,649 | 12,535 | 13,310 | ||||||||||||||
EBITDA | 23,938 | 26,375 | 28,344 | 28,691 | 29,102 | ||||||||||||||
Depreciation | -14,621 | -15,558 | -16,695 | -16,156 | -15,792 | ||||||||||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
EBIT | 9,317 | 10,817 | 11,649 | 12,535 | 13,310 | ||||||||||||||
Net interest expense | -4,394 | -4,115 | -4,256 | -3,867 | -3,854 | ||||||||||||||
Associates & JCEs | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other income | -334 | 31 | 0 | 0 | 0 | ||||||||||||||
Earnings before tax | 4,589 | 6,733 | 7,392 | 8,668 | 9,456 | ||||||||||||||
Income tax | -1,156 | -1,460 | -1,626 | -1,907 | -2,080 | ||||||||||||||
Net profit after tax | 3,433 | 5,272 | 5,766 | 6,761 | 7,375 | ||||||||||||||
Minorities | -269 | -362 | -395 | -464 | -506 | ||||||||||||||
Other items | 1,343 | 0 | 0 | 0 | 0 | ||||||||||||||
Preferred dividends | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Normalised NPAT | 4,506 | 4,911 | 5,371 | 6,297 | 6,870 | ||||||||||||||
Extraordinary items | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Reported NPAT | 4,506 | 4,911 | 5,371 | 6,297 | 6,870 | ||||||||||||||
Dividends | -2,396 | -2,336 | -2,954 | -3,463 | -3,778 | ||||||||||||||
Transfer to reserves | 2,111 | 2,575 | 2,417 | 2,834 | 3,091 | ||||||||||||||
Valuations and ratios | |||||||||||||||||||
Reported P/E (x) | 3.4 | 12.6 | 11.5 | 9.8 | 9.0 | ||||||||||||||
Normalised P/E (x) | 3.4 | 12.6 | 11.5 | 9.8 | 9.0 | ||||||||||||||
FD normalised P/E (x) | 3.4 | 12.6 | 11.5 | 9.8 | 9.0 | ||||||||||||||
Dividend yield (%) | 15.5 | 3.8 | 4.8 | 5.6 | 6.1 | ||||||||||||||
Price/cashflow (x) | 0.9 | 3.7 | 2.4 | 2.7 | 2.7 | ||||||||||||||
Price/book (x) | 0.5 | 1.8 | 1.7 | 1.6 | 1.5 | ||||||||||||||
EV/EBITDA (x) | 4.8 | 4.6 | 4.0 | 3.8 | 3.6 | ||||||||||||||
EV/EBIT (x) | 12.3 | 11.2 | 9.7 | 8.7 | 7.9 | ||||||||||||||
Gross margin (%) | 27.0 | 27.9 | 29.6 | 30.8 | 31.7 | ||||||||||||||
EBITDA margin (%) | 46.7 | 47.2 | 48.4 | 48.2 | 48.0 | ||||||||||||||
EBIT margin (%) | 18.2 | 19.4 | 19.9 | 21.1 | 22.0 | ||||||||||||||
Net margin (%) | 8.8 | 8.8 | 9.2 | 10.6 | 11.3 | ||||||||||||||
Effective tax rate (%) | 25.2 | 21.7 | 22.0 | 22.0 | 22.0 | ||||||||||||||
Dividend payout (%) | 53.2 | 47.6 | 55.0 | 55.0 | 55.0 | ||||||||||||||
ROE (%) | 15.3 | 15.3 | 15.5 | 16.9 | 17.0 | ||||||||||||||
ROA (pretax %) | 8.7 | 9.9 | 10.7 | 11.8 | 12.7 | ||||||||||||||
Growth (%) | |||||||||||||||||||
Revenue | 9.6 | 9.1 | 4.8 | 1.6 | 1.8 | ||||||||||||||
EBITDA | 23.0 | 10.2 | 7.5 | 1.2 | 1.4 | ||||||||||||||
Normalised EPS | -4.6 | -72.8 | 9.4 | 17.3 | 9.1 | ||||||||||||||
Normalised FDEPS | -4.6 | -72.8 | 9.4 | 17.3 | 9.1 | ||||||||||||||
Source: Company data, Verdhana estimates |
Cashflow statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY23 | FY24 | FY25F | FY26F | FY27F | ||||||||||||||
EBITDA | 23,938 | 26,375 | 28,344 | 28,691 | 29,102 | ||||||||||||||
Change in working capital | -944 | -4,180 | 3,446 | -129 | -151 | ||||||||||||||
Other operating cashflow | -5,549 | -5,575 | -5,883 | -5,774 | -5,935 | ||||||||||||||
CF from operations | 17,444 | 16,620 | 25,907 | 22,788 | 23,016 | ||||||||||||||
Capital expenditure | -12,783 | -9,938 | -14,000 | -14,000 | -14,500 | ||||||||||||||
Free cashflow | 4,661 | 6,682 | 11,907 | 8,788 | 8,516 | ||||||||||||||
Reduction in investments | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Net acquisitions | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Dec in other LT assets | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Inc in other LT liabilities | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Adjustments | -1,520 | -6,128 | -8,476 | 0 | 1,000 | ||||||||||||||
CF after investing acts | 3,141 | 554 | 3,431 | 8,788 | 9,516 | ||||||||||||||
Cash dividends | -2,396 | -2,336 | -2,954 | -3,463 | -3,778 | ||||||||||||||
Equity issue | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Debt issue | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Convertible debt issue | |||||||||||||||||||
Others | -5,071 | 1,047 | 0 | 0 | 0 | ||||||||||||||
CF from financial acts | -7,467 | -1,289 | -2,954 | -3,463 | -3,778 | ||||||||||||||
Net cashflow | -4,326 | -735 | 477 | 5,325 | 5,738 | ||||||||||||||
Beginning cash | 9,516 | 5,190 | 4,454 | 4,931 | 10,256 | ||||||||||||||
Ending cash | 5,190 | 4,454 | 4,931 | 10,256 | 15,994 | ||||||||||||||
Ending net debt | 48,681 | 50,412 | 41,459 | 36,134 | 31,396 | ||||||||||||||
Balance sheet (IDRbn) | |||||||||||||||||||
As at 31 Dec | FY23 | FY24 | FY25F | FY26F | FY27F | ||||||||||||||
Cash & equivalents | 5,190 | 4,454 | 4,931 | 10,256 | 15,994 | ||||||||||||||
Marketable securities | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Accounts receivable | 3,144 | 3,282 | 2,974 | 3,022 | 3,078 | ||||||||||||||
Inventories | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other current assets | 7,146 | 7,142 | 7,418 | 7,514 | 7,627 | ||||||||||||||
Total current assets | 15,480 | 14,878 | 15,323 | 20,792 | 26,699 | ||||||||||||||
LT investments | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Fixed assets | 72,861 | 74,143 | 71,448 | 69,292 | 68,000 | ||||||||||||||
Goodwill | 20,504 | 20,117 | 20,117 | 20,117 | 20,117 | ||||||||||||||
Other intangible assets | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other LT assets | 5,878 | 5,249 | 5,249 | 5,249 | 5,249 | ||||||||||||||
Total assets | 114,722 | 114,387 | 112,137 | 115,450 | 120,065 | ||||||||||||||
Short-term debt | 9,457 | 10,378 | 0 | 0 | 0 | ||||||||||||||
Accounts payable | 746 | 912 | 956 | 971 | 989 | ||||||||||||||
Other current liabilities | 23,932 | 19,719 | 23,089 | 23,089 | 23,089 | ||||||||||||||
Total current liabilities | 34,134 | 31,009 | 24,045 | 24,060 | 24,078 | ||||||||||||||
Long-term debt | 44,414 | 44,488 | 46,390 | 46,390 | 47,390 | ||||||||||||||
Convertible debt | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other LT liabilities | 2,465 | 2,238 | 2,238 | 2,238 | 2,238 | ||||||||||||||
Total liabilities | 81,013 | 77,735 | 72,673 | 72,688 | 73,706 | ||||||||||||||
Minority interest | 2,963 | 3,153 | 3,549 | 4,012 | 4,518 | ||||||||||||||
Preferred stock | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Common stock | 18,875 | 18,880 | 18,880 | 18,880 | 18,880 | ||||||||||||||
Retained earnings | 11,871 | 14,618 | 17,035 | 19,869 | 22,960 | ||||||||||||||
Proposed dividends | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other equity and reserves | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Total shareholders' equity | 30,746 | 33,498 | 35,915 | 38,749 | 41,840 | ||||||||||||||
Total equity & liabilities | 114,722 | 114,387 | 112,137 | 115,450 | 120,065 | ||||||||||||||
Liquidity (x) | |||||||||||||||||||
Current ratio | 0.45 | 0.48 | 0.64 | 0.86 | 1.11 | ||||||||||||||
Interest cover | 2.1 | 2.6 | 2.7 | 3.2 | 3.5 | ||||||||||||||
Leverage | |||||||||||||||||||
Net debt/EBITDA (x) | 2.03 | 1.91 | 1.46 | 1.26 | 1.08 | ||||||||||||||
Net debt/equity (%) | 158.33 | 150.49 | 115.44 | 93.25 | 75.04 | ||||||||||||||
Per share | |||||||||||||||||||
Reported EPS (IDR) | 558.92 | 152.27 | 166.53 | 195.26 | 213.01 | ||||||||||||||
Norm EPS (IDR) | 558.92 | 152.27 | 166.53 | 195.26 | 213.01 | ||||||||||||||
FD norm EPS (IDR) | 558.92 | 152.27 | 166.53 | 195.26 | 213.01 | ||||||||||||||
BVPS (IDR) | 3,813.35 | 1,038.68 | 1,113.62 | 1,201.49 | 1,297.34 | ||||||||||||||
DPS (IDR) | 297.14 | 72.42 | 91.59 | 107.39 | 117.15 | ||||||||||||||
Activity (days) | |||||||||||||||||||
Days receivable | 19.7 | 21.0 | 19.5 | 18.4 | 18.4 | ||||||||||||||
Days inventory | 0.0 | 0.0 | 0.0 | 0.0 | |||||||||||||||
Days payable | 7.8 | 7.5 | 8.3 | 8.5 | 8.6 | ||||||||||||||
Cash cycle | 11.9 | 13.5 | 11.2 | 9.9 | 9.7 | ||||||||||||||
Source: Company data, Verdhana estimates |
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Increased from IDR 3,450 | IDR 3,600 |
Closing price 10 February 2025 | IDR 1,920 |
Implied upside | +87.5% |
Market Cap (USD mn) | 3,789.6 |
ADT (USD mn) | 2.1 |
M cap (USDmn) | 3,789.6 |
Free float (%) | 14.0 |
3-mth ADT (USDmn) | 2.1 |
(%) | 1M | 3M | 12M |
Absolute (IDR) | -19.3 | -11.9 | -19.2 |
Absolute (USD) | -20.1 | -15.6 | -22.7 |
Rel to Jakarta Stock Exchange Composite Index | -14.4 | -4.5 | -12.3 |
Erwin Wijaya (erwin.wijaya@verdhana.id)